Top Banner

of 41

53991583 Overview IV Therapy

Jun 04, 2018

Download

Documents

jp_sure
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
  • 8/13/2019 53991583 Overview IV Therapy

    1/41

    Test 1- WALDEN

    IV THERAPY:

    1. PURPOSE- To access the venous circulation in order to dra !lood "or la!orator# screens

    and dia$nostic tests or to ad%inister "luids& electrol#tes& %edications& !lood& !lood

    'roducts &and nutritional su''le%ents.

    Indicated "or situations hen oral or other 'arenteral routes are not

    a''ro'riate.

    (ontinuous IV ad%inistration

    Inter%ittent IV is used 'ri%aril# "or IV %edication ad%inistration

    )olus increase in %edication i%%ediatel#

    IV %edications !#'ass the en*#%atic 'rocess o" the liver

    +ursin$ Res'onsi!ilities

    ,noin$ IV sets and their "unctions

    (alculatin$ IV dri' rates

    iin$ and dilutin$ %edications in IV "luids

    ,noin$ the %edications& 'ur'oses& and side e""ects

    +ursin$ Res'onsi!ilities continued

    Assess%ent o" the client& site& in"iltration& rates& adverse reactions& thera'eutic actions

    IV route is the "astest onset o" %edication ad%inistration& hoever& once in/ected& the %edication

    can not !e retrieved

    IV route could 'rovide a direct route "or conta%ination ith 'atho$ens

    (losel# %onitor the client "or adverse reactions

    IV (onsiderations

    Is "luid loss severe or li"e-threatenin$0

    hat is %issin$0

    hat is current health status0 (o- %or!idities: cardiac& renal& liver& 'ul%onar#& I 2 O

  • 8/13/2019 53991583 Overview IV Therapy

    2/41

    3ail# ei$ht 4 "luids calculated on chan$es in current ei$ht

    5To 6ilo$ra%s o" ei$ht $ain is e7uivalent to 8 liters o" "luid $ain

    9 'ounds 8.9 liters "luid

    Restorin$ "luids !# IV

    h#: "luid; !lood loss& 'recautionar#

  • 8/13/2019 53991583 Overview IV Therapy

    3/41

    -

  • 8/13/2019 53991583 Overview IV Therapy

    4/41

    Use o" nettin$ to secure

    Avoid restraints 'recaution

    ental status assess%ent

    EI3

    >au$e and luid Rate

    8B $au$e @#ello 19-89%l;%in

    88 $au$e @!lue 8C-FC %l;%in

    8G $au$e @'in6 9G-C9 %l;%in @%aintenance rate

    1 $au$e @$reen 9-1G9 %l;%in

    @hen lar$e !olus ra'id in"usion needed

    >eriatrics

    88 4 8B $au$e

    Tourni7uet %a# not !e necessar#

    Position hand de'endent

    +o sla''in$ see !o 19- F 'a$e BBD Techni7ues.

    Re%e%!er $eriatric care.

    (entral venous catheters

    central linesJ

    ultilu%en or sin$le lu%en non-tunneled

  • 8/13/2019 53991583 Overview IV Therapy

    5/41

    aintenance @"lushin$ K shi"t- R+

    (entral lines cont.

    Uses

    $lood sampling

    C%& monitoring

    Continuous' intermittent drug infusions

    iagnostic testing

    Simultaneous infusion of seeral medications

    %iscous or high-olume fluids ' blood

    "& (total parenteral nutrition)

    PI(( IV access @alternate access

    Peri'herall# inserted central catheters @ar%

  • 8/13/2019 53991583 Overview IV Therapy

    6/41

    Su!clavian& /u$ular& or "e%oral catheter

    Te%'orar# vascular access

    To 'orts - !lue and red

    Used "or acute he%odial#sis

    3 to insert

    Sutured to s6in

    S'ecial trainin$ to access

    Accounta!ilit# and In"usion Thera'#

    The R+ is accounta!le "or 6noin$

    *hat is ordered

    *hy it is intended

    +mpact on the patient

    Any possible side effects

    ,o to administer the infusion

    ,o to maintain the infusion

    ,o to discontinue properly

    ,o to document appropriately

    R+ Res'onsi!ilities

    The R+ re%ains accounta!le and res'onsi!le "or all dele$ated tas6s and %ust have a clear

    6noled$e o" the nursin$ sco'e o" 'ractice relative to assess%ent& 'lannin$& i%'le%entation& and

    evaluation o" in"usion thera'#& as ell as le$al res'onsi!ilities associated ith dele$ation o"

    nursin$ care activities.J @I+S& 8GGG

    R+?s Res'onsi!ilities

    3ele$ate certain nursin$ tas6s to licensed and unlicensed 'ersonnel

    Still res'onsi!le "or tas6s dele$ated

    ust evaluate others co%'etenc#& instruct the%& and veri"# 'ro'er trainin$

  • 8/13/2019 53991583 Overview IV Therapy

    7/41

    Res'onsi!ilities %a# var# a%on$ states and e%'lo#ers

    (o%'ati!ilit#

    +urse is res'onsi!le to veri"# co%'ati!ilit# o" "luids ith %edication ad%inistered via IV

    Or i" a edication is in the IV "luid and a dru$ is $iven inter%ittentl#

    +urse %ust %a6e certain "luids and dru$s are co%'ati!le.

    IV Thera'#

    R+ vs.

  • 8/13/2019 53991583 Overview IV Therapy

    8/41

    B. (hec6 to see i" the anti!iotic is co%'ati!le ith the soluitions in"usin$.

    (O+SI3ER A>E+(Y IV THERAPY PO

  • 8/13/2019 53991583 Overview IV Therapy

    9/41

    IV Thera'# that is ordered "re7uentl# "or short 'eriods o" ti%e.

    EN:

    .ocephin 1gm +%&$ / 12 hours doses

    emerol 23mg +%& / 4- hours &. pain

    IV 'ush @IVP or IV 'i$$#!ac6 @IVP)& secondar#

    Re7uires tu!in$ and site chan$e 7 B-D8 hours

    re7uent site %onitorin$

    luid in"used recorded on chart 7 shi"t

    IVP @IV 'ush %edications

    (hec6 order

    Pre'are %edications and chec6 co%'ati!ilit# ith "luids

    Assess site

    Select 'ort 'roi%al to 'atient

    (lean 'ort ith alcohol sa!

    lush ith 1G%l o" +S !e"ore %edication

    Insert;attach %edication s#rin$e

    Occlude IV tu!in$ a!ove 'ort @'inch

    Pull !ac6 $entl# to as'irate !lood return @%a# not $et

    In/ect %edication in desi$nated ti%e "ra%e @loo6 u' in dru$ !oo6

    Release tu!in$ i" "luids runnin$ - i" saline loc6& "lush ith 1G%l o" +S and loc6

    S%all volu%e needs to han$ hi$her

    IV PUSH

    3ra u' correct dose into a 1G%< s#rin$e.

    Veri"# dose ith second nurse

    Then add additional saline to s#rin$e to e7ual 1G %

  • 8/13/2019 53991583 Overview IV Therapy

    10/41

    Pause.

  • 8/13/2019 53991583 Overview IV Therapy

    11/41

    :ay be anyhere from

  • 8/13/2019 53991583 Overview IV Therapy

    12/41

    89Q

    H#'o'roteine%ia

    Volu%e E'ansion

    Others are 3etran& s#nthetic colloid %ade o" $lucose-

    o!ili*es interstitial ede%a

    Hetastarch @Hes'an ade "ro% corn.

    o!ili*es interstitial ede%a

    Volu%e e'anders

    Plas%a 'las%anate @Plas%a 'rotein "raction

    (ontains hu%an 'las%a 'roteins in +or%al Saline @+S.

    Increases seru% colloid os%otic 'ressure

    T#'es o" intravenous solutions

    Isotonic

    ormal Saline (S) ! .ingers actate(.)

    etrose in ater (3*)

    H#'otonic

    043= ormal Saline

    0

  • 8/13/2019 53991583 Overview IV Therapy

    13/41

  • 8/13/2019 53991583 Overview IV Therapy

    14/41

    Push "luid into cells : h# %i$ht e see %ental status chan$e0

    h# is 39 isotonic in the !a$

    A+3 HYPOTO+I( in the vein

    >lucose enters the vascular co%'art%ent

    Is then ra'idl# %eta!oli*ed !# the

  • 8/13/2019 53991583 Overview IV Therapy

    15/41

  • 8/13/2019 53991583 Overview IV Therapy

    16/41

    aintain ater !alance

    Pro%ote sodiu% diuresis

    3etrose in Saline

    39+S

    391;8 +S

    31G +S

    Pro%otes diuresis

    (orrect %oderate "luid loss

    Prevent al6alosis

    Provides calories and sodiu% chloride

    Electrol#tes

  • 8/13/2019 53991583 Overview IV Therapy

    17/41

    h# is an EI3 used "or concentrated !olus ad%inistered.

    hat is a concentrated !olus.

    TP+

    +utritional ade7uate h#'ertonic solution consistin$ o" $lucose and other nutrients andelectrol#tes $iven throu$h an indellin$ 'eri'heral or central line

    Used as intervention in severe cases o" %alnutrition.

    TP+ 000000

    h# should e %onitor >lucose ever# C hours0

    h# should e not allo the solution container o" TP+ run out0

    h# should e closel# %onitor T P R and );P0 )(0 In"usion site0 h# is ase'sis so vital0

    TO START A+ IV==

    3e%onstration in la!

    E7ui'%ent and Su''lies

    IV catheter @8B>A& 88>A& 8G>A& 1>A& 1C>A

    IV start 6it @dra'e& cleanin$ and antise'tic 're's& dressin$s& ta'e& la!el& tourni7uet& trans'arent

    dressin$

    >

  • 8/13/2019 53991583 Overview IV Therapy

    18/41

    luids vs. PR+ loc6 @saline or he'arin

    Tu!in$ and etension

    edication; )lood ad%inistration

    Pu%'s& dial-a-"lo& volu%e control device @$ravit#

    (hildren

    Aller$# to iodine& late& or ta'e

    Ar% !oard

    Trans'arent dressin$; ta'e

    Practice correctl#

    Assess%ent "or initiatin$ IV thera'#

    Asse%!le correct su''lies

    Revie 3?s order

    9 ri$hts

    Assess "or clinical "actors; conditions

    Assess 'revious e'erience; e'ectations

    (onsider "uture treat%ents

    Aller$ies; la! data @!etadine ta'e

    Plannin$ "or initiatin$ IV thera'# @$oals

    2 E )alance and VS ill return to nor%al

    IV line ill !e 'atent

    Site ill !e !eni$n

    (lient ill understand 'ur'ose

    IV site selection

    A$e and status o" 'atient

    Pur'ose o" the in"usion

  • 8/13/2019 53991583 Overview IV Therapy

    19/41

    3uration o" thera'#

    (ondition o" 'atient?s veins

  • 8/13/2019 53991583 Overview IV Therapy

    20/41

    Use distal vein to 'roi%al

    ar% co%'ress

    (hec6 arterial 'ulse to ensure ade7uate !lood "lo to "ill veins

    hen 're' i'e accordin$ to 'olic#:

    (&'& say distal to proimal)

    (hloro-'re'

    3o not !lot4 this re%oves anti%icro!ial 'ro'erties

    SO ho do e 6no ho "ast to re$ulate the "lo rate00

    (ount dro's 19 seconds B $tts ; %inute

    Re$ulate "lo rate

    Ad/ust rate as 'rescri!ed !# health care 'rovider

    "oo slo @ ein clots 'occlude line or client goes into circulatory 'C% collapse

    "oo fast @ luid olume ecess (%B)

    (alculate rates on 'a'er.

    (O+T.

    . Per"or% veni'uncture at 8G-FG de$ree an$le.

  • 8/13/2019 53991583 Overview IV Therapy

    21/41

    3ocu%ent 'rocedure

    Patient Teachin$

    hen to call the nurse

    .edness pain blood dressing loose

    lo stops blood in tubing

    +% pump alarm

    A%!ulate ith IV 'ole& %ove%ent

    As6 "or assistance hen needed.

    3ocu%entation

    o" atte%'ts @I" several %a# chart %ulti'le atte%'tsJ

    T#'e o" "luid and "lo rate

    Insertion site @A o" catheter

    hen in"usion !e$un

    Re%e%!er i" it is not docu%ented- IT 3I3 +OT HAPPE+

    3O(UE+TATIO+ ENAPA IV catheter

    8 atte%'ts

    < rist

    39 M +S at 1GG;hr

    )lood dran

    19GG 88>A IV to < rist 8 atte%'ts& !lood dran and sent to la!& 39 M +S 1GG %l;hr 'er

    'u%'. Site clear& no redness or ede%a. -------------------------------------------------+ +urse R+

    5TIP5

    An#ti%e #ou do an#thin$ ith a 'atient?s IV @han$ "luids& $ive %edications& ala#s chec6 the IV

    site. I" the IV is not "unctional& then #ou are doin$ nothin$ "or the 'atient. OR #ou %a# !e

  • 8/13/2019 53991583 Overview IV Therapy

    22/41

  • 8/13/2019 53991583 Overview IV Therapy

    23/41

    (irculator# overload

    Phle!itis @thro%!o'hle!itis

    3e"inition: In"la%%ation o" a vein& o"ten acco%'anied !# "or%ation o" a clot

    S 2 SN: Indicated !# 'ain& increased s6in te%'& er#the%a alon$ 'ath o" vein @cord alon$ vein

    (lots %a# occur

    TN: Sto' in"usion and discontinue IV

    Bleate etremity arm moist compresses

    .estart ne +% if +% therapy is needed

    .otate sites / 48-E2,

    (auses: 3ru$ irritation& trau%a to vein& in"ection& stasis& i%%o!ili*ation& IV catheter in 'lace too

    lon$

    In"iltration

    3e"inition: 'rocess in hich a "luid 'asses throu$h the tissues

    S 2 SN: Indicated !# sellin$ and 'ossi!le 'ittin$ ede%a& 'allor& coolness& 'ain at insertion site&

    'ossi!le decrease or a!sent "lo rate

    TN: Sto' in"usion and discontinue IV.

    .estart +% in ne location if +% therapy indicated

    *arm compresses and eleation of etremity

    (auses: IV catheter not in vein& in surroundin$ tissue

    Etravasatinon

    RE>ITI+E around IV SITE

    3O not elevate ar%s

    3O not a''l# cold or ar% co%'ress

    +oti"# health care 'rovider and "ollo instructions.

    hat is di""erence in I+I

  • 8/13/2019 53991583 Overview IV Therapy

    24/41

    3e"inition: collection o" !lood in tissue or s6in due to trau%a& a6a: !ruise

    S 2 SN: discoloration& 'ain& locali*ed ede%a to site

    Usuall# sel" li%itin$

    TN: Initiall# %oderate 'ressure %a# reduce a%ount o" !ruisin$

    (auses: trau%a or inco%'lete he%ostasis a"ter sur$er#

    )leedin$

    (an occur around veni'uncture site and under s6in

    (o%%on in clients on he'arin& ASA

    A''l# 'ressure dressin$ to site and docu%ent

    E

  • 8/13/2019 53991583 Overview IV Therapy

    25/41

    3e"inition: entr# o" air into venous circulation

    (auses: Secondar# to trau%a& IV tu!in$ not 'ri%ed

  • 8/13/2019 53991583 Overview IV Therapy

    26/41

    ritten order: !lood co%'onent& volu%e& rate o" in"usion

    hen a client is to receive !lood& the nurse is lar$el# res'onsi!le "or its sa"e ad%inistration.

    A)O and Rh TYPE

    A)O- t#'e o" anti$en co%'onents that R)(?s have.

    T#'e A A anti$en

    T#'e ) ) anti$en

    T#'e A) !oth

    T#'e O none

    Rh- anti$enic su!stance 'resent in R)(?s

    I" have Rh

    I" do not have Rh-

    Autolo$ous trans"usion

    (ollect !lood "ro% client 'rior to e'ected sur$ical 'rocedure& rein"use client ith !lood in

    sur$er

    Salva$e !lood in sur$er# and ad%inister.

    Autolo$ous- donate on !lood.

    )lood (o%'onents

    hole )lood

    PR)(

    Platelets @Pranuloc#te (oncentrations

    Plas%a

    (lottin$ actors

  • 8/13/2019 53991583 Overview IV Therapy

    27/41

    Other volu%e e'anders

    hole )lood

    Used in esan$uinations@)leedin$ 'atient

    (ontains all !lood 'roducts

    Usuall# contains BGG %l -

    USE3 hen !oth volu%e and cells are needed

    hole )lood

    R)(& 'las%a& 'las%a 'roteins ith CF %l o" anticoa$ulant.

    9GG %l;unit

    A)O identical and Rh "actor %ust %atch

    Rarel# indicated

    Outco%es: 'revention; resolution o" h#'ovole%ic shoc6 and ane%ia

    Ris6: volu%e overload

    PR)(?s

    Red !lood cells ith anticoa$ulant-'reservative @no clottin$ "actors

    Unit si*e- 89G to BGG%l;unit

    A)O co%'ati!le& Rh "actor %atch

    >iven "re7uentl# !lood loss- sur$er#& trau%a

    GQ 'las%a has !een re%oved.

    Outco%es: resolution o" ane%ia

    PR)(s

    >iven "or acute and chronic ane%ia &

    )lood loss

    3esired over hole !lood in cardiovascular 2 renal co%'ro%ised& and elderl# clients !ecause

    PR)(s contain less "luid volu%e.

  • 8/13/2019 53991583 Overview IV Therapy

    28/41

    Platelets @P

  • 8/13/2019 53991583 Overview IV Therapy

    29/41

    (r#o'reci'itate

    Antihe%o'hilliac "actor VIII and "actor NIII

    9-1G%l;unit

    (ontains no R)( and a s%all volu%e o" 'las%a

    A)O co%'ati!ilit# not needed

    Outco%es: correction o" "actor VIII& v& NIII and "i!rino$en de"icienc#& cessation o" !leedin$

    (r#o'reci'itate

    (o%'onents clottin$ "actors

    USES: he%o'hilia& "i!rino$en de"icienc#&

    3I(.

    Plas%a 3erivatives

    Al!u%in- al!u%in& $lo!ulin and other 'roteins

    Anti!odies destro#ed durin$ 'rocessin$- co%'ati!ilit# not a "actor

    Ra'id in"usion %a# cause h#'otension& !ut 89Q al!u%in can cause a si$ni"icantl# increased

    !lood 'ressure !ecause o" its a!ilit# to dra "luid into the intravascular s'ace

    (annot trans%it he'atitis or HIV in"ection due to the 'asteuri*ation 'rocess used to 're'are

    Outco%es: %aintain; ac7uire ade7uate !lood 'ressure and volu%e su''ort

    (lottin$ actors

  • 8/13/2019 53991583 Overview IV Therapy

    30/41

    Outco%e: 'ro%ote circulator# volu%e and tissue 'er"usion !# ra'idl# e'andin$ 'las%a volu%e

    +ot a su!stitute "or !lood or its co%'onents

    Volu%e e'anders

    Re%ain in vascular s'ace and increase os%otic 'ressure

    Plas%a e'ander include detran& hetastarch and 'las%a al!u%in

    Al!u%in

    A

    Al!u%in is availa!le in 9 Q and 89 Q

    9 Q al!u%in e'ands vascular s'ace %< "or %+E3

    O!tain venous access

    Validate Vital si$ns

    Re7uest !lood release

    (on"ir% !lood acce'ta!ilit#

    In"use !lood

    onitor durin$ the trans"usion

    atch "or trans"usion reaction

    Vials %ust !e la!eled and a la!el on 't ar% to %atch.

    I+ORE3 (O+SE+T

    An in"or%ed consent UST !e o!tained and docu%ented 'rior to !lood ad%inistration

    E'lanation to the client or "a%il# %e%!er o" %edical indications "or ho%olo$ous @ho%olo$ous

    vs. autolo$ous trans"usion and its !ene"its& ris6s& and alternatives

    Assess client histor# "or an# 'revious trans"usions and client?s res'onse

  • 8/13/2019 53991583 Overview IV Therapy

    31/41

    VE+OUS A((ESS

    +eed lar$e !ore IV @8G $au$e or lar$er

    a# use a 88 >A "or adults ith s%all veins or children- not !est o'tion

    (an use a VA3 @central line& !ut a lar$e volu%e o" re"ri$erated !lood in"used ra'idl# into theventricle can cause cardiac d#srh#th%ias

    ar%in$ the !lood can reduce the ris6 o" this co%'lication

    (aution

    Ra'id in"usion ith cold !lood can cause d#srrh#th%ia

    I +E(ESSARY TO use s%all $ua$e %a# need to as6 la! to s'lit unit into to !a$s. S%aller

    needle can !e used "or 'latelets& al!u%in and clottin$ "actors.

    )lood Release

    )e"ore $oin$ to !lood !an6& several thin$s %ust !e done: 'ri%e !lood tu!in$ ith +S onl# and

    start +S at ,VO& ta6e VS& 're%edicate i" ordered& !andin$J the 'atient

    )lood %ust !e 'ic6ed u' "ro% the !lood !an6 !# an R+

    The na%e and identi"ication nu%!er o" the reci'ient %ust !e 'rovided and a 'er%anent record

    o" this in"o %aintained in !lood !an6

    )lood !an6 is re"rid$erator

    There is a !oo6 ith lot nu%!ers and 'atient identi"ication data.

    Record

    FG %inute indo

    )lood %ust !e started ithin thirt# %inutes o" o!tainin$ unit "ro% la!

    USE )

  • 8/13/2019 53991583 Overview IV Therapy

    32/41

    Second chec6 is done at !edside !# 8 R+sW co%'are na%e& nu%!er& A)O& Rh co%'at.& !lood

    !and

    (hec6 date

    Ins'ect !a$ "or lea6s& clots& ecessive air

    The orst reactions to !lood are usuall# due to %isidenti"ication o" !lood or client

    TU)I+>

    ust use !lood tu!in$ ith "ilter.

    E%'t# to "ull

    REA(TIO+S

    GQ o" he%ol#tic trans"usion reactions are "ro% i%'ro'er 'atient to 'roduct identi"ication

  • 8/13/2019 53991583 Overview IV Therapy

    33/41

    +o other %edications to !e $iven in sa%e tu!in$- EVER @

  • 8/13/2019 53991583 Overview IV Therapy

    34/41

  • 8/13/2019 53991583 Overview IV Therapy

    35/41

    hat i" the rate o" in"usion slos ithout si$ns o" in"iltration00

    Su$$est "lush line ith sterile nor%al saline.

    hat i"0

    Si$ns and s#%'to%s o" VE as short o" !reath or crac6les occurs000

    Sto' or slo the in"usion

    Elevate the HO)

    Vital si$ns

    +oti"# 3

    Antici'ate 3iuretic; or'hine sul"ate

    O#$en

    Aller$ic Trans"usion Reaction see Techni7ues C.

    re7uenc# 1Q

    S 2 S: Urticaria& "lushin$& itchin$& @no "ever

    $t: antihista%ines& trans"usion %a# continue

    Prevention: treat 'ro'h#lacticall# ith antihista%ines 2 aceta%ino'hine

    e'ine'hrine& corticosteroids "or severe reaction

    e!rile Trans"usion Reaction

    re7uenc#: G.9-1Q

    S 2 SN: "ever and;or 'ul%onar# s#%'to%s& sudden chills and "ever& HA& "lushin$& aniet#&

    %uscle 'ain

    $t: I" "ever and;or 'ul%onar# s#%'to%s- 3O +OT resu%e in"usion& treat shoc6& $ive

    anti'#retics

    Prevention: (onsider leu6oc#te 'roducts hich have !een "iltered& ashed or "ro*en.

    Acute He%ol#tic Trans"usion Reaction

    re7uenc#: 1:89&GGG

    S 2 SN: chills& "ever& )P& "lushin$& tach#cardia& tach#'nea& h#'otension& vascular colla'se&

  • 8/13/2019 53991583 Overview IV Therapy

    36/41

  • 8/13/2019 53991583 Overview IV Therapy

    37/41

    hat i"0000

    I" reaction is sus'ected& should nurse turn saline on and allo saline to "lo throu$h tu!in$0

    h# han$ saline ith !lood trans"usion and not detrose0

    Anser: 3etrose cause coa$ulatio o" donor !lood.

    Ana'h#lactic Trans"usion Reaction

    re7uenc#: 1:19G&GGG

    S 2 SN: aniet#& urticaria& hee*in$& d#s'nea

    'ro$ressin$ to c#anosis& shoc6& cardiac arrest

    $t: Sto' trans"usion& (PR i" needed& have E'ine'hrine read# "or in/ection

    Prevention: >iven !lood "ro% I$A de"icient donors or 'las%a ash

    3O +OT restart trans"usion

    3ela#ed trans"usion reactions

    3ela#ed he%ol#tic

    He'atitis ) and (

    HIV

    Iron Overload

    est +ile Virus

    a# occur ee6s to %onths a"ter the trans"usion.

    )lood (ollection

    )lood s'eci%en collection

    ost co%%onl# used dia$nostic aids in the care and evaluation o" clients

    Yield valua!le in"or%ation a!out nutritional& he%atolo$ical& %eta!olic& i%%une and !ioche%ical

    status

    Screen "or earl# si$ns o" disease& 'lot current treat%ent course& and %onitor res'onse to thera'#

    a# !e 'er"or%ed !# R+& or other trained 'ersonnel

  • 8/13/2019 53991583 Overview IV Therapy

    38/41

  • 8/13/2019 53991583 Overview IV Therapy

    39/41

    )lood tu!es

    I3 la!els "or tu!es

    A !utter"l#

    Sterile s#rin$e

    Vaccutainer tu!e

    Sterile dou!le ended needle 8G-89>A

    Anaero!ic and aero!ic culture !ottles

    Su''lies de'end on hat !lood tests are ordered

    (onsider- !e"ore #ou stic6

    Antici'ate client?s aniet#

    Assess "or an# 'ossi!le ris6s

    Is the 'atient a!le to coo'erate0

    (ontraindicated sites0

    So%e s'eci%ens re7uire s'ecial collection re7uire%ents- 6no "acilit# 'olic#

    hich tu!e do I use0

    Pur'le - !lood cell counts @()(

    Solid red - dru$ levels in !lood

    S'ec6led red - che%istr#; electrol#te levels

    )lue - clottin$ ti%es

    >reen - cardiac s'eci"ic

    ZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZZ

    555THIS VARIES RO A(I

  • 8/13/2019 53991583 Overview IV Therapy

    40/41

    >ather su''lies

    ash hands

    Provide 'rivac#& 'osition 'atient

    A''l# tourni7uet @1 %in %a

    A''l# $loves

    3eter%ine !est site- strai$ht& 'ro%inent vein

    (leanse site and allo to dr#

    Pull s6in taut& hold needle at 19-FG de$ree an$le ith !evel u'

    Procedure cont.

    Slol# insert into vein- "eel the 'o'J

    ithdra !lood hile 6ee'in$ needle sta!ili*ed

    Release tourni7uet hen !lood collected

    A''l# sterile 'ressure dressin$

    3is'ose o" su''lies 'ro'erl#

    The )lood dra and the IV line

    I" ne IV& dra !lood "ro% hu! !e"ore "lushin$

    I" it is an old IV line- TOO )A3

    hen drain$ !lood "or la!& avoid the ar% ith the IV 4 it %a# alter la! results

    I" have to use sa%e ar%& turn o"" "luids "or 1G %inutes and use site distal to IV i" 'ossi!le

    Handlin$ )lood S'eci%ens

    Rotate !lood tu!es $entl# a"ter dra

  • 8/13/2019 53991583 Overview IV Therapy

    41/41

    3is'osal o" %aterials

    +eedles- shar's

    I" not saturated ith !lood %a# $o into re$ular $ar!a$e. I" saturated ith !lood %ust $o into

    !ioha*ard rece'tacle.

    IV "luid !a$s can $o into the $ar!a$e hen drained& tu!in$ %ust $o in !ioha*ard container

    )lood collection de%onstrated in la!

    Vaccutainer

    )utter"l#

    ro% IV site

    S%all orld

    Positive "luid dis'lace%ent. (